SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR

This publication has 21 references indexed in Scilit:

• Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
  Proceedings of the National Academy of Sciences, 1987
• Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates
  Nature, 1984
• ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE CYTOTOXIN
  The Lancet, 1984
• New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
  Microbiological Reviews, 1983
• Duration of Infection-Derived Immunity to Cholera
  The Journal of Infectious Diseases, 1981
• Selective vs, Nonselective Media and Direct Plating vs. Enrichment Technique in Isolation of Vibrio cholerae: Recommendations for Clinical Laboratories
  The Journal of Infectious Diseases, 1980
• The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979
• Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979
• Mechanisms of Disease and Immunity in Cholera: A Review
  The Journal of Infectious Diseases, 1977
• Response of Man to Infection with Vibrio cholerae. II. Protection from Illness Afforded by Previous Disease and Vaccine
  The Journal of Infectious Diseases, 1974